Cargando…
Initial Experience With the Next-Generation Resolute Onyx Zotarolimus-Eluting Stent in Symptomatic Intracranial Atherosclerotic Disease
Background and Purpose: Intracranial atherosclerotic disease (ICAD) is a common cause of stroke worldwide. Although there are different endovascular options for the treatment of symptomatic ICAD (sICAD), it is still controversial. Herein, we aim to study the safety and efficacy of a new generation o...
Autores principales: | Hassan, Ameer E., Mohammaden, Mahmoud H., Rabah, Rani Ramsey, Tekle, Wondwossen G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555826/ https://www.ncbi.nlm.nih.gov/pubmed/33101179 http://dx.doi.org/10.3389/fneur.2020.570100 |
Ejemplares similares
-
One-year clinical outcomes of patients implanted with a Resolute Onyx™ zotarolimus-eluting stent
por: Tam, Chor Cheung, et al.
Publicado: (2017) -
Double-vessel very late stent thrombosis following Resolute Onyx zotarolimus eluting stents implantation in an octogenarian
por: Kassimis, George, et al.
Publicado: (2018) -
Short-term stent coverage of second-generation zotarolimus-eluting durable polymer stents: Onyx one-month optical coherence tomography study
por: Roleder, Tomasz, et al.
Publicado: (2019) -
Zotarolimus-eluting stent-induced hypersensitivity pneumonitis
por: Shin, Hong-Won, et al.
Publicado: (2013) -
Comparison of short-term clinical outcomes between Resolute Onyx zotarolimus-eluting stents and everolimus-eluting stent in patients with acute myocardial infarction: Results from the Korea Acute Myocardial infarction Registry (KAMIR)
por: Kim, Yongcheol, et al.
Publicado: (2019)